Patients with hypertension with an elevated screening ARR and a low renin, but normal aldosterone suppression during confirmatory test, are considered to have a subtle form of PA and are typically managed with mineralocorticoid receptor antagonist [6]. This evidence concerns the gene REN and Hypertension.